Fig. 1
Point at which JAKi therapy usually started (multiple response). b = biological; c = conventional; DMARD = disease-modifying antirheumatic drug
Fig. 1 | BMC Rheumatology
Point at which JAKi therapy usually started (multiple response). b = biological; c = conventional; DMARD = disease-modifying antirheumatic drug